We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Industry Requests Fewer Trials, More FDA Accountability
Industry Requests Fewer Trials, More FDA Accountability
July 8, 2011
As the FDA conducts a comprehensive review of its existing regulations, industry is taking the opportunity to seek fewer clinical trials, and is asking for a revamp of the agency’s clinical hold policy and changes in its adverse event reporting policies.